Efficacy and Safety of Dorocontin(®) versus Sustac(®) in the Treatment of Stable Angina Pectoris: A Randomized, Double-Blind Comparative Trial

Background: Development of generic drugs has numerous benefits in terms of cost-efficiency and availability. Slow-release nitroglycerin is a vasodilator drug commonly prescribed for patients with angina pectoris. Objective: The objective of this study was to compare the efficacy and safety of generi...

Descripción completa

Detalles Bibliográficos
Autores principales: Panahi, Yunes, Pishgoo, Bahram, Dadjou, Yahya, Mehdirad, Manouchehr, Soflaei, Sara Saffar, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientia Pharmaceutica 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475798/
https://www.ncbi.nlm.nih.gov/pubmed/26171326
http://dx.doi.org/10.3797/scipharm.1406-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475798/
https://www.ncbi.nlm.nih.gov/pubmed/26171326
http://dx.doi.org/10.3797/scipharm.1406-16

Ejemplares similares